Le lieutenant-général (ret) J.O. Michel Maisonneuve dirigera la campagne de financement à l’appui de la recherche et des traitements pour les vétérans vivant avec la douleur chronique
10 nov. 2022 07h00 HE
|
Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 10 nov. 2022 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer la nomination du lieutenant-général...
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
26 sept. 2022 09h00 HE
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OAK pain completed enrollment with last patient (n=120) dosedNo limiting toxicities have been encountered during the trial to date. Patients are now being monitored for...
Canadian Military Veterans Complete Hike to Bring Awareness to Chronic Pain
30 août 2022 07h32 HE
|
Chronic Pain Centre of Excellence for Canadian Veterans
HAMILTON, Ontario, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Seven military Veterans living with chronic pain from across Canada completed the first-ever Military Veterans Alpine Challenge (Alpine...
Peripheral Nerve Stimulation Pioneer Dr. Marc Huntoon Joins SPR Therapeutics as Director of Medical Affairs
02 août 2022 16h23 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Aug. 02, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics is proud to announce the addition of Dr. Marc Huntoon to the company as Director of Medical Affairs. In this role, he will provide...
SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022
14 juil. 2022 10h54 HE
|
SPR Therapeutics, Inc.
CLEVELAND, July 14, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced today that two presentations highlighting SPRINT® PNS in treating chronic pain will be featured at the American Society of...
Global Neuromodulation Market to Reach $4.3 Bn Globally, by 2030, at 6.2% CAGR: Says AMR
15 juin 2022 07h47 HE
|
Allied Market Research
Portland, OR, June 15, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Neuromodulation Market was estimated at $2.48 billion in 2020, and is...
Medical Case Management Market Size Worth $5.22Bn, Globally, by 2028 at 3.5% CAGR - Exclusive Report by The Insight Partners
25 avr. 2022 14h06 HE
|
The Insight Partners
New York, April 25, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Medical Case Management Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Mode of...
Prolonged Temporary Neurostimulation Treatment Period Offered by the SPRINT® PNS System May Optimize Pain Management Care Pathway While Reducing Healthcare Costs
15 mars 2022 10h31 HE
|
SPR Therapeutics, Inc.
CLEVELAND, March 15, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced publication of a study in the Journal of Pain Research demonstrating how a longer initial treatment period may better...
HealthCheck360 Partners With Fern Health to Provide Digital Solutions for Chronic Musculoskeletal Pain
07 févr. 2022 08h00 HE
|
HealthCheck360
DUBUQUE, Iowa, Feb. 07, 2022 (GLOBE NEWSWIRE) -- HealthCheck360, a leader in population health management and well-being programs for employers, is expanding its program to address the underlying...
RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
24 janv. 2022 07h00 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...